The biochemical pathology of aspirin-induced gastric damage

Agents and Actions
K D Rainsford


No abstract listed.


Nov 1, 1973·The Journal of Pharmacy and Pharmacology·R D BirtleyJ C Pennington
Aug 1, 1974·The Journal of Pharmacy and Pharmacology·S OkabeK Takagi
Feb 1, 1966·Proceedings of the Society for Experimental Biology and Medicine·L R Johnson
Jan 18, 1969·Lancet·F O Stephens, K B Lawrenson
Sep 1, 1974·Toxicology and Applied Pharmacology·R Menassé-Gdynia, P Krupp
Dec 1, 1968·The Journal of Pharmacy and Pharmacology·K D RainsfordM J SMITH
Sep 1, 1969·Japanese Journal of Pharmacology·K Takagi, K Kawashima
Aug 1, 1970·The Journal of Pharmacy and Pharmacology·D J Harford, M J SMITH
Oct 1, 1971·The Journal of Pharmacy and Pharmacology·M J SMITH, P D Dawkins
Dec 1, 1974·Biochemical Medicine·J C ManglaA A Rubulis
Jul 26, 1972·Nature: New Biology·R J FlowerJ R Vane
Nov 8, 1973·The New England Journal of Medicine·J R LeonardsR Niemczura
May 1, 1974·The American Journal of Digestive Diseases·P W DodgeS Tekeli
Feb 1, 1974·Scandinavian Journal of Clinical and Laboratory Investigation·T G JörgensenG W Peskin
Jan 1, 1972·Annual Review of Medicine·R Menguy
Oct 1, 1973·The American Journal of Digestive Diseases·D J St JohnW G de Boer
May 15, 1974·Biochemical Pharmacology·R J Flower, J R Vane
Mar 1, 1974·The American Journal of Digestive Diseases·N D Yeomans, D J St John
Jun 1, 1968·Archives of Internal Medicine·W B ThorsenJ F Morrissey
Jan 1, 1968·Digestion·F O StephensE K van der Ven
Jan 1, 1968·The American Journal of Digestive Diseases·R H Salter
May 1, 1972·Journal of Pharmaceutical Sciences·C H MorrisW G Hansen
Mar 1, 1966·Clinical Pharmacology and Therapeutics·C DavisonR DeVine
Jan 21, 1967·British Medical Journal·D N CROFT, P H WOOD
Dec 14, 1968·British Medical Journal·K GOULSTON, A R Cooke
Aug 9, 1969·British Medical Journal·A R Cooke, K GOULSTON
Oct 1, 1969·Journal of Pharmaceutical Sciences·J R Leonards, G Levy
Nov 1, 1969·The American Journal of Digestive Diseases·D H KuiperH M Pollard
Oct 1, 1971·Gut·C D NeedhamD F Kerridge
Oct 9, 1970·Science·D A BrodieK F Hooke
Jul 1, 1969·British Journal of Pharmacology·D T DaviesR S Tonks
Sep 1, 1969·The Biochemical Journal·G BallP Yates
Jun 8, 1967·The New England Journal of Medicine·H W Davenport
Jul 1, 1967·Journal of Pharmaceutical Sciences·E MorrisJ E Christian
Jul 22, 1967·Nature·M RowlandE J Eyring
Apr 1, 1956·The American Journal of the Medical Sciences·P G FRICK
Nov 1, 1958·British Medical Journal·L T STUBBE
Aug 1, 1961·The American Journal of Medicine·R N PIERSONR P KEATING
Dec 2, 1961·The Medical Journal of Australia·R A DOUGLAS, E D JOHNSTON
Mar 10, 1962·British Medical Journal·L T STUBBE van HEULEN
Mar 1, 1963·Experimental Cell Research·J D VIAL, H ORREGO
Dec 1, 1963·Proceedings of the Society for Experimental Biology and Medicine·A ROBERT, J E NEZAMIS
Dec 1, 1963·Proceedings of the Society for Experimental Biology and Medicine·J F EMELE, J SHANAMAN
May 23, 1964·British Medical Journal·G ROSS, C H GRAY
May 23, 1964·British Medical Journal·R A IRVINE, W B ROBERTSON
Nov 1, 1964·Annals of the Rheumatic Diseases·L F GAST
Dec 1, 1964·The Journal of Pharmacy and Pharmacology·G B WEST
Feb 1, 1965·Gut·G H JENNINGS
Dec 1, 1950·The Journal of Clinical Investigation·S J GRAY, K STERLING
Jul 1, 1948·Journal of Neurosurgery·S W GROSS
Sep 1, 1948·The British Journal of Venereal Diseases·E J MOYNAHAN
Mar 31, 1940·The Journal of Experimental Medicine·K Landsteiner, R A Harte


Feb 1, 1980·Digestive Diseases and Sciences·K J IveyW J Krause
Nov 1, 1980·Agents and Actions·K D Rainsford, M W WHITEHOUSE
Nov 1, 1980·Agents and Actions·K D RainsfordK Brune
Jan 1, 1979·European Journal of Drug Metabolism and Pharmacokinetics·J D GuptaW Ablett
Oct 19, 1993·European Journal of Pharmacology·M DohiK Yoshida
Jan 1, 1979·Pharmacology & Therapeutics. Part B: General & Systematic Pharmacology·R Menassé
Jan 1, 1979·Pharmacology & Therapeutics. Part B: General & Systematic Pharmacology·K BruneA Schweitzer
Jan 1, 1987·Pharmacology & Therapeutics·R O DayJ de Jager
Dec 1, 1977·Australian and New Zealand Journal of Medicine·G B HoweG G Graham
Dec 1, 1982·Journal of Pharmacological Methods·B I Ghanayem, A E Ahmed
Apr 1, 1983·Toxicology and Applied Pharmacology·M W WHITEHOUSE, K D Rainsford
Jun 15, 1981·Toxicology and Applied Pharmacology·M P Holsapple, G K Yim
Apr 1, 1989·The American Journal of Medicine·R T Schoen, R J Vender
Jan 1, 1978·Biochemical Pharmacology·D Waldron-EdwardJ Labat-Robert
Jan 1, 1978·Pharmacological Research Communications·M M GoldenbergA W Castellion
Jan 1, 1980·Pharmacological Research Communications·K D Rainsford, M W WHITEHOUSE
Oct 1, 1980·British Journal of Clinical Pharmacology·K BruneA Schweitzer
Dec 1, 1979·The Journal of Pharmacy and Pharmacology·R Walker, K A Wilson
Oct 1, 1984·The Journal of Pharmacy and Pharmacology·J C Dearden, R M Nicholson
Aug 1, 1983·Xenobiotica; the Fate of Foreign Compounds in Biological Systems·C G CurtisC Rhodes
Aug 1, 1981·Pain·Steven I BaskinAllan H Goldfarb
May 1, 1980·Biochemical Pharmacology·K D Rainsford, M W WHITEHOUSE
Feb 1, 1978·The Journal of Pharmacy and Pharmacology·K D Rainsford
Jul 1, 1976·The Journal of Pharmacy and Pharmacology·K D Rainsford, M W WHITEHOUSE
Aug 1, 1988·Scottish Medical Journal·B J DaneshC D Forbes

Related Concepts

Age Factors
Alcohol Consumption
Anti-Inflammatory Agents
Ascorbic Acid Deficiency
Blood Group Antigens
Structure of Pyloric Gland

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Lipidomics & Rhinovirus Infection

Lipidomics can be used to examine the lipid species involved with pathogenic conditions, such as viral associated inflammation. Discovered the latest research on Lipidomics & Rhinovirus Infection.

Alzheimer's Disease: MS4A

Variants within the membrane-spanning 4-domains subfamily A (MS4A) gene cluster have recently been implicated in Alzheimer's disease in genome-wide association studies. Here is the latest research on Alzheimer's disease and MS4A.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Torsion Dystonia

Torsion dystonia is a movement disorder characterized by loss of control of voluntary movements appearing as sustained muscle contractions and/or abnormal postures. Here is the latest research.

Generating Insulin-Secreting Cells

Reprogramming cells or using induced pluripotent stem cells to generate insulin-secreting cells has significant therapeutic implications for diabetics. Here is the latest research on generation of insulin-secreting cells.

Central Pontine Myelinolysis

Central Pontine Myelinolysis is a neurologic disorder caused most frequently by rapid correction of hyponatremia and is characterized by demyelination that affects the central portion of the base of the pons. Here is the latest research on this disease.

Epigenome Editing

Epigenome editing is the directed modification of epigenetic marks on chromatin at specified loci. This tool has many applications in research as well as in the clinic. Find the latest research on epigenome editing here.

Related Papers

Pneumonologia polska
A Szczeklik
Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine
H Sakakibara
Clinical Reviews in Allergy & Immunology
L T Vaszar, D D Stevenson
© 2021 Meta ULC. All rights reserved